SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-446708
Filing Date
2012-11-01
Accepted
2012-11-01 16:42:06
Documents
12
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d398228d10q.htm 10-Q 627454
2 EX-21.1 d398228dex211.htm EX-21.1 3031
3 EX-31.1 d398228dex311.htm EX-31.1 6242
4 EX-31.2 d398228dex312.htm EX-31.2 6227
5 EX-32.1 d398228dex321.htm EX-32.1 3628
6 EX-32.2 d398228dex322.htm EX-32.2 3608
  Complete submission text file 0001193125-12-446708.txt   3806573

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT idix-20120930.xml EX-101.INS 412647
8 XBRL TAXONOMY EXTENSION SCHEMA idix-20120930.xsd EX-101.SCH 42870
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE idix-20120930_cal.xml EX-101.CAL 40536
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE idix-20120930_def.xml EX-101.DEF 99494
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE idix-20120930_lab.xml EX-101.LAB 307074
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idix-20120930_pre.xml EX-101.PRE 205898
Mailing Address 60 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address 60 HAMPSHIRE STREET CAMBRIDGE MA 02139 617-995-9800
IDENIX PHARMACEUTICALS INC (Filer) CIK: 0001093649 (see all company filings)

IRS No.: 450478605 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-49839 | Film No.: 121174068
SIC: 2834 Pharmaceutical Preparations